FDA Inspection
Chongqing Kangle Pharmaceutical Co., LtdChongqing Kangle Pharmaceutical Co., Ltd – FDA Inspection, Sep 5, 2025
Record Details
This FDA Inspection record concerns Chongqing Kangle Pharmaceutical Co., Ltd, with an inspection on September 5, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 5, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 0ae9e965-0baa-4ae0-ae7f-b42f8e6e62b6
Inspection Facts
- Inspection number
- 1286254
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Kangle Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Kangle Pharmaceutical Co., Ltd
- FDA Inspection 1064345 - 2018-07-26
- FDA Inspection 912714 - 2015-01-30
- FDA Inspection 783920 - 2012-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.